证券记录 · 已归档季度
BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare · Biotechnology
14被追踪持有人
+1Δ持有人
26.41M持有股份
$198.06M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +7.7% ·
股份流向 +24.7% ·
净新建仓位 +7.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | +4 | 139.04M | $1.39B | +8 | −4 |
| Q1 2026 | 108 | +4 | 130.67M | $1.24B | +14 | −10 |
| Q4 2025 | 103 | -1 | 127.11M | $991.41M | — | −1 |
| Q3 2025 | 22 | +2 | 89.66M | $680.51M | +2 | −1 |
| Q2 2025 | 18 | +1 | 80.75M | $723.56M | +1 | — |
| Q1 2025 | 14 | +1 | 26.41M | $198.06M | +1 | — |
| Q4 2024 | 13 | -2 | 21.17M | $159.22M | — | −2 |
| Q3 2024 | 14 | +4 | 16.62M | $126.32M | +4 | — |
| Q2 2024 | 10 | — | 15.77M | $97.44M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 7.81M | +4.2% | $58.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 4.96M | +2.8% | $37.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 4.96M | +2.8% | $37.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 3.81M | +382.6% | $28.60M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 3.05M | -4.1% | $22.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 2.05M | +15.3% | $15.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 1.59M | +404.1% | $11.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 1.59M | +404.1% | $11.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.20M | +43.1% | $9.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.20M | +43.1% | $9.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 1.20M | +43.1% | $9.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.20M | +43.1% | $9.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 1.20M | +43.1% | $9.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 605.22K | +11.0% | $4.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 574.19K | +122.1% | $4.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 574.19K | +122.1% | $4.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Norges Bank ✦ (被动) | 287.96K | -45.1% | $2.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 194.15K | -51.9% | $1.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 134.29K | +5.9% | $1.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Wellington Management ✦ | 91.35K | +2.6% | $685,111 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 91.35K | +2.6% | $685,111 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 91.35K | +2.6% | $685,111 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 91.35K | +2.6% | $685,111 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 44.06K | 新增 | $330,480 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Gotham Asset Management | $330,480 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 298 持有人, 245.96M 股份, $2.30B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据